Featured session at Bethesda MPS Day, which took place on November 9, 2023. Dr. Gautam Mahajan’s presentation highlights the development of a human Vagina-on-a-Chip model, enabling the study of host-microbiome […]| Emulate
Women’s reproductive health has historically been underserved in biomedical research. Conditions such as bacterial vaginosis, cervical infections, and heavy menstrual bleeding affect millions worldwide, yet remain poorly understood and under-treated. […]| Emulate
Advanced cell culture system for disease research and drug development, including Organ-Chips, hardware, and software applications.| Emulate
By Jim Corbett, CEO, Emulate Drug discovery is at a crossroads. With nearly 90% of clinical trial candidates failing to reach FDA approval, the need for more predictive, human-relevant models […]| Emulate
Next-generation Organ-on-a-Chip technology allows researchers to emulate biology and predict human response. Get started today.| Emulate
Discover how FDA, NIH and Congress are fast tracking alternatives to animal testing—and how Organ on a Chip technology is reshaping drug development.| Emulate
This blog explores the landscape of NAMs, explains how they can be used synergistically, and highlights the key factors driving their recent momentum.| Emulate
In this blog, we’re recapping the exciting highlights from the 4th annual MPS World Summit conference that took place in Brussels, Belgium from June 9-13. Read on to catch up […] The post Expanding the Frontiers of Human Biology with Organ-on-a-Chip Technology: Highlights from the 2025 MPS World Summit appeared first on Emulate.| Emulate
Learn how complex in vitro models are allowing drug developers to tackle challenging diseases for the first time| Emulate
Explore commercially available Organ-Chip models of the human intestine, liver, kidney, and more.| Emulate
2024 was filled with groundbreaking discoveries that showcase the transformative potential of Organ-on-a-Chip technology.| Emulate
Drug-induced liver injury (DILI) remains a persistent challenge in drug development, endangering patient safety and delaying the availability of critical therapies. Just days ago, the FDA issued a warning about […] The post Ocaliva, Azelaprag, and the Continuing Challenge of Drug-Induced Liver Injury: A Call for Human-Relevant Models appeared first on Emulate.| Emulate
Organ-on-a-Chip technology continues to mature and gain adoption by the scientific community as a revolutionary tool for creating novel models of human-centric biology. In this ChipChat blog, we spoke with […] The post ChipChat: What is a “Big Toe-on-a-Chip”? Exploring the Endless Possibilities of Organ-Chips with Emulate Chief Scientific Officer Lorna Ewart, PhD appeared first on Emulate.| Emulate
Recently, we announced that the Emulate Liver-Chip S1 was accepted into the FDA’s ISTAND pilot program. To learn more, we sat down with Dr. Lorna Ewart, Chief Scientific Officer at […] The post Emulate Liver-Chip S1 Accepted into FDA’s ISTAND Pilot Program. What’s Next? appeared first on Emulate.| Emulate
Learn what microphysiological systems are and how they allow scientists to gain more human-relevant insights compared to conventional models.| Emulate
Learn about Organ-on-a-Chip technology and why it's setting the stage for the next generation of drug development and research.| Emulate
Read why research may need to end its reliance on NHPs, the gold standard for lab animals, and adopt advanced in vitro models.| Emulate
